4//SEC Filing
Abuse Deterrent Pharma, LLC 4
Accession 0001567619-21-012643
CIK 0000786947other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 11:00 AM ET
Size
8.6 KB
Accession
0001567619-21-012643
Insider Transaction Report
Form 4
Abuse Deterrent Pharma, LLC
10% Owner
Transactions
- Conversion
Convertible Promissory Note
2021-06-09−6,877,500→ 0 totalExercise: $0.16From: 2019-06-28→ Common Stock (42,984,375 underlying) - Conversion
Common Stock
2021-06-09$0.16/sh+42,984,375$6,877,500→ 42,984,375 total
Holdings
- 1,782,531
Warrant to Purchase Common Stock
Exercise: $0.53From: 2017-07-24Exp: 2022-07-23→ Common Stock (1,782,531 underlying)
Footnotes (2)
- [F1]The note bears interest at the rate of 7.5% per annum. On the conversion date, all principal and $877,500 of interest under the note was converted into the Issuer's common stock. For each $0.16 converted, AD Pharma received one share of common stock.
- [F2]This note is convertible, at the election of AD Pharma, at any time prior to repayment of the note and matures on July 1, 2023.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
IncorporatedKY
Related Parties
1- filerCIK 0001782327
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 11:00 AM ET
- Size
- 8.6 KB